Xenon Pharmaceuticals Inc.
XENE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,053 | $3,081 | $2,387 | $1,363 |
| - Cash | $143 | $149 | $57 | $176 |
| + Debt | $9 | $11 | $10 | $8 |
| Enterprise Value | $2,920 | $2,943 | $2,340 | $1,195 |
| Revenue | $0 | $0 | $9 | $18 |
| % Growth | – | -100% | -48.8% | – |
| Gross Profit | -$3 | -$168 | $9 | $18 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$236 | -$211 | -$128 | -$78 |
| % Margin | – | – | -1,354% | -423.5% |
| Net Income | -$234 | -$182 | -$125 | -$79 |
| % Margin | – | – | -1,328.9% | -427.8% |
| EPS Diluted | -3.01 | -2.73 | -2.06 | -1.77 |
| % Growth | -10.3% | -32.5% | -16.4% | – |
| Operating Cash Flow | -$181 | -$145 | -$98 | -$70 |
| Capital Expenditures | -$3 | -$6 | -$3 | -$2 |
| Free Cash Flow | -$184 | -$151 | -$101 | -$72 |